Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response

Protein-based markers that classify tumor subtypes and predict therapeutic response would be clinically useful in guiding patient treatment. We investigated the LC-MS/MS-identified protein biosignatures in 39 baseline breast cancer specimens including 28 HER2-positive and 11 triple-negative (TNBC) t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: He, Jianbo, Whelan, Stephen A., Lu, Ming, Shen, Dejun, Chung, Debra U., Saxton, Romaine E., Faull, Kym F., Whitelegge, Julian P., Chang, Helena R.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3202144/
https://ncbi.nlm.nih.gov/pubmed/22110952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/896476
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars